Skip to content

Single blastocyst transfer after preimplantation genetic scanning for patients of high risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

Single blastocyst transfer after preimplantation genetic scanning for patients of high risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003388
Enrollment
Unknown
Registered
2013-04-27
Start date
2013-06-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sterility

Interventions

PGS:single thawed blastcyst transfer after preimplantation genetic scanning
control:signle blastcyst transfer after frozen

Sponsors

Reproductive and genetic Hospital of Citic- Xiangya
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Age <=35y, BMI <=27kg/m2; 2. Polycystic ovary syndrome (PCOS) patients; 3. the first or second treatment cycle; 4. bilateral ovaries, FSH< 8miu/ml; 5. high risk of OHSS needs to cancel the fresh embryo transfer; 6. signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Endometriosis disease; 2. unilateral or bilateral hydrosalpinx (B ultrasound examination); 3. uterine malformation, multiple uterine myoma, uterine intramural myoma >3cm, submucous myoma; 4. intrauterine adhesions history, history of uterine cavity effusion of unknown cause; 5. abnormal childbearing history, more than two times of unexplained abortion; 6. other reasons need to preimplantation genetic diagnosis (PGD), preimplantation genetic scanning (PGS); 7. the number of good quality embryos on day three of oocyte retrieval (6 cell grade II) less than five; 8. on the day of oocyte retrieval, spermatozoon is only C grade (WHO); 9. the previous history of abnormal thyroid function; 10. history of hypertension, systolic pressure >=150mmHg, DBP >=90mmHg; 11. previous or ongoing epilepsy, diabetes, cardiovascular disease, gastrointestinal diseases, liver disease, kidney disease, lung disease; 12. the woman of smoking, alcoholism, drug addiction; 13. cervical biopsy showed CIN I level and above.

Design outcomes

Primary

MeasureTime frame
live birth rate;

Secondary

MeasureTime frame
pregnancy rate;implantation rate;

Countries

China

Contacts

Public ContactLin Ge
linggf36@yahoo.com.cn+86 13187057355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026